David T. Davies

1.4k citations

32 papers · 750 indexed · h-index 16

Co-authors: Martin Everett Andrew F. Parsons Pamela Brown Steven Dabbs J. M. Wilson Marc Lemonnier Graham E. Jones Colin W. G. Fishwick
Topics: Antibiotic Resistance in Bacteria (8 papers)Chemical Synthesis and Analysis (5 papers)Cancer therapeutics and mechanisms (5 papers)
Cited by: Molecular Medicine Toxicology Applied Microbiology and Biotechnology
Journals: Accounts of Chemical Research Chemical Communications Journal of Medicinal Chemistry
Partner nations: United Kingdom United States Italy

In The Last Decade

David T. Davies

32 papers receiving 726 citations

Peers

Countries citing papers authored by David T. Davies

Since Specialization

Citations

This map shows the geographic impact of David T. Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Davies more than expected).

Fields of papers citing papers by David T. Davies

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T. Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Davies. The network helps show where David T. Davies may publish in the future.

Co-authorship network of co-authors of David T. Davies

This figure shows the co-authorship network connecting the top 25 collaborators of David T. Davies. A scholar is included among the top collaborators of David T. Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David T. Davies. David T. Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Meropenem-ANT3310, a unique β-lactam-β-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant Acinetobacter baumannii 2024 ·Antimicrobial Agents and Chemotherapy ·Magdalena Zalacaín,(unknown),(unknown),Ian Morrissey,Stephen Hawser,Kirsty Holden,(unknown),David T. Davies,(unknown),Carole A. Sable,Adeline Ledoux,(unknown),Jérôme Castandet,(unknown),Martin Everett,Marc Lemonnier	6
2	Chemical Optimization of Selective Pseudomonas aeruginosa LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models 2023 ·ACS Infectious Diseases ·Martin Everett,David T. Davies,(unknown),(unknown),(unknown),Jérôme Castandet,(unknown),Christopher N. LaRock,Doris L. LaRock,(unknown),Jean‐Denis Docquier,T. David Pallin,(unknown),(unknown),Magdalena Zalacaín,Marc Lemonnier	15
3	Pseudomonas aeruginosa elastase (LasB) as a therapeutic target 2021 ·Drug Discovery Today ·Martin Everett,David T. Davies	60
4	Virtual Screening Approach to Identifying a Novel and Tractable Series ofPseudomonas aeruginosaElastase Inhibitors 2021 ·ACS Medicinal Chemistry Letters ·(unknown),David T. Davies,(unknown),Jérôme Castandet,(unknown),Michael S. Bodnarchuk,Jonathan Sutton,(unknown),Mark Jones,Andrew K. Forrest,T. David Pallin,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Srinivasu Pothukanuri,Marc Lemonnier,Martin Everett	11
5	Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria 2021 ·Accounts of Chemical Research ·David T. Davies,Martin Everett	27
6	Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae 2018 ·Antimicrobial Agents and Chemotherapy ·Martin Everett,(unknown),Alicia Coelho,Jérôme Castandet,(unknown),(unknown),(unknown),David T. Davies,(unknown),Magdalena Zalacaín,Ian Morrissey,Sophie Magnet,Kirsty Holden,Peter Warn,Filomena De Luca,Jean‐Denis Docquier,Marc Lemonnier	84
7	The Synthesis of Group 10 and 11 Metal Complexes of 3,6,9‐Trithia‐1‐(2,6)‐pyridinacyclodecaphane and Their Use in A³‐Coupling Reactions 2017 ·European Journal of Organic Chemistry ·(unknown),(unknown),David T. Davies,James Raftery,Íñigo J. Vitórica‐Yrezábal,Robin G. Pritchard,Huimin Zhou,Peter Quayle	12
8	Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases 2016 ·Bioorganic & Medicinal Chemistry Letters ·Timothy J. Miles,Alan J. Hennessy,B.D. Bax,Gerald Brooks,Barry S. Brown,Pamela Brown,(unknown),(unknown),Steven Dabbs,David T. Davies,(unknown),Ilaria Giordano,Jennifer L. Hoover,Graham E. Jones,(unknown),Roger E. Markwell,Elisabeth A. Minthorn,(unknown),Michael N. Gwynn,Neil D. Pearson	33
9	Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: Structure based design, synthesis, SAR and antimicrobial activity 2014 ·European Journal of Medicinal Chemistry ·(unknown),Lloyd G. Czaplewski,(unknown),David T. Davies,(unknown),Colin W. G. Fishwick	47
10	Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases 2011 ·Bioorganic & Medicinal Chemistry Letters ·Timothy J. Miles,(unknown),Gerald Brooks,Pamela Brown,(unknown),Steven Dabbs,David T. Davies,David L. Downie,Susanne Eyrisch,Ilaria Giordano,Michael N. Gwynn,Alan J. Hennessy,Jennifer L. Hoover,Jianzhong Huang,Graham E. Jones,Roger E. Markwell,Stephen Rittenhouse,Hong Xiang,Neil D. Pearson	33
11	A stereoselective, Sm(ii)-mediated approach to decorated cis-hydrindanes: synthetic studies on faurinone and pleuromutilin 2011 ·Organic & Biomolecular Chemistry ·(unknown),David Sucunza,Laura C. Miller,Matthew Helm,Madeleine Helliwell,David T. Davies,David J. Procter	22
12	A Flexible, Stereoselective Approach to the Decorated cis‐Hydrindane Skeleton: Synthesis of the Proposed Structure of Faurinone 2008 ·Chemistry - A European Journal ·(unknown),David Sucunza,Laura C. Miller,David T. Davies,David J. Procter	25
13	A catalytic asymmetric protocol for the enantioselective synthesis of 3(2H)-furanones 2007 ·Chemical Communications ·Charles M. Marson,(unknown),(unknown),Simon J. Coles,Michael B. Hursthouse,David T. Davies	39
14	Model studies on a synthetically facile series of N-substituted phenyl-N′-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists 1999 ·Bioorganic & Medicinal Chemistry ·Steven M. Bromidge,Steven Dabbs,David T. Davies,Susannah Davies,D. Malcolm Duckworth,Ian T. Forbes,(unknown),P. J. Ham,Graham E. Jones,(unknown),(unknown),Kevin M. Thewlis,Dolatrai M. Vyas,Thomas P. Blackburn,Vicky Holland,G.A. Kennett,Graham J. Riley,Martyn Wood	5
15	Novel and Selective 5-HT_2C/2B Receptor Antagonists as Potential Anxiolytic Agents: Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines 1998 ·Journal of Medicinal Chemistry ·Steven M. Bromidge,Steven Dabbs,David T. Davies,D. Malcolm Duckworth,Ian T. Forbes,P. J. Ham,Graham E. Jones,Frank D. King,(unknown),(unknown),Kevin M. Thewlis,Paul Wyman,Frank E. Blaney,Christopher Naylor,Fiona P. Bailey,Thomas P. Blackburn,Vicky Holland,G.A. Kennett,Graham J. Riley,Martyn Wood	53
16	Manganese(III) reactions in N-heterocycle synthesis: The preparation of substituted pyrrolidinones 1998 ·Tetrahedron Letters ·David T. Davies,(unknown),Andrew F. Parsons	15
17	ChemInform Abstract: Chemistry of Pseudomonic Acid (VIII). Part 15. Synthesis and Antibacterial Activity of a Series of 5‐Alkyl, 5‐Alkenyl, and 5‐ Heterosubstituted Oxazoles. 1996 ·ChemInform ·Pamela Brown,David T. Davies,Peter J. O’Hanlon,(unknown)	2
18	Structure-activity relationships of some arylglycine analogues and catechol isosteres of BRL 36650, a 6.ALPHA.-formamido penicillin. 1990 ·The Journal of Antibiotics ·(unknown),George Burton,David T. Davies,(unknown),T. C. SMALE,Robert Southgate,Andrew V. Stachulski,MICHAEL J. BASKER,(unknown)	2
19	Synthesis and biological activity of a series of piperazine-2,3-dione containing penicillins and 6.ALPHA.-formamidopenicillins. I. Derivatives substituted at C(5) or C(6) of the piperazine ring. 1989 ·The Journal of Antibiotics ·David T. Davies,Frank P. Harrington,(unknown),Robert Southgate	2
20	The synthesis of anthracyclinones-ii 1984 ·Tetrahedron ·Alison E. Ashcroft,David T. Davies,James K. Sutherland	13

About David T. Davies

David T. Davies is a scholar working on Molecular Medicine, Toxicology and Organic Chemistry, having authored 32 papers that have together received 750 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (8 papers), Chemical Synthesis and Analysis (5 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Molecular Medicine (189 citations), Toxicology (50 citations) and Applied Microbiology and Biotechnology (29 citations). David T. Davies has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Martin Everett, Andrew F. Parsons, Pamela Brown, Steven Dabbs, J. M. Wilson, Marc Lemonnier, Graham E. Jones, Colin W. G. Fishwick, Alan J. Hennessy and Timothy J. Miles. Their work appears in journals such as Accounts of Chemical Research, Chemical Communications and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact